These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35862898)

  • 1. Perioperative Management of Extended-release Buprenorphine.
    Hickey TR; Henry JT; Edens EL; Gordon AJ; Acampora G
    J Addict Med; 2023 Jan-Feb 01; 17(1):e67-e71. PubMed ID: 35862898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Pain Management for a Tibial Plateau Fracture Shortly After a Buprenorphine XR Depot Injection: A Case Report.
    Sivanathan L; Logan E; Popovski K; Goel A; Hauck T; Ladha KS
    J Addict Med; 2022 Sep-Oct 01; 16(5):599-601. PubMed ID: 35093985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose buprenorphine: perioperative precautions and management strategies.
    Roberts DM; Meyer-Witting M
    Anaesth Intensive Care; 2005 Feb; 33(1):17-25. PubMed ID: 15957687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New slow-release buprenorphine formulations for optimization of opioid substitution].
    Soyka M; Pogarell O
    Nervenarzt; 2019 Sep; 90(9):932-937. PubMed ID: 31399813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative Buprenorphine Management: A Multidisciplinary Approach.
    Hickey T; Abelleira A; Acampora G; Becker WC; Falker CG; Nazario M; Weimer MB
    Med Clin North Am; 2022 Jan; 106(1):169-185. PubMed ID: 34823729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period.
    Lembke A; Ottestad E; Schmiesing C
    Pain Med; 2019 Mar; 20(3):425-428. PubMed ID: 29452378
    [No Abstract]   [Full Text] [Related]  

  • 7. Extended-release monthly buprenorphine injection.
    Cuperfain AB; Costa T; Chopra N
    CMAJ; 2023 Jan; 195(1):E14. PubMed ID: 36623857
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuation of Buprenorphine to Facilitate Postoperative Pain Management for Patients on Buprenorphine Opioid Agonist Therapy.
    Mehta D; Thomas V; Johnson J; Scott B; Cortina S; Berger L
    Pain Physician; 2020 Mar; 23(2):E163-E174. PubMed ID: 32214293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients on Buprenorphine Formulations Undergoing Surgery.
    Champagne K; Date P; Forero JP; Arany J; Gritsenko K
    Curr Pain Headache Rep; 2022 Jun; 26(6):459-468. PubMed ID: 35460492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder in custodial setting - a case series.
    Soyka M; Groß G
    Am J Drug Alcohol Abuse; 2021 Sep; 47(5):599-604. PubMed ID: 34407703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for Continuing Buprenorphine in the Perioperative Period.
    Li AH; Schmiesing C; Aggarwal AK
    Clin J Pain; 2020 Oct; 36(10):764-774. PubMed ID: 32520814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort.
    Morgan JR; Walley AY; Murphy SM; Chatterjee A; Hadland SE; Barocas J; Linas BP; Assoumou SA
    Drug Alcohol Depend; 2021 Aug; 225():108764. PubMed ID: 34051547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series.
    Ritvo AD; Calcaterra SL; Ritvo JI
    J Addict Med; 2021 May-Jun 01; 15(3):252-254. PubMed ID: 32925232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine in the Treatment of Chronic Pain.
    Rudolf GD
    Phys Med Rehabil Clin N Am; 2020 May; 31(2):195-204. PubMed ID: 32279723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To Stop or Not, That Is the Question: Acute Pain Management for the Patient on Chronic Buprenorphine.
    Anderson TA; Quaye ANA; Ward EN; Wilens TE; Hilliard PE; Brummett CM
    Anesthesiology; 2017 Jun; 126(6):1180-1186. PubMed ID: 28511196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure.
    Shulman M; Choo TH; Scodes J; Pavlicova M; Wai J; Haenlein P; Tofighi B; Campbell ANC; Lee JD; Rotrosen J; Nunes EV
    J Subst Abuse Treat; 2021 May; 124():108292. PubMed ID: 33771287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia.
    Larance B; Degenhardt L; Grebely J; Nielsen S; Bruno R; Dietze P; Lancaster K; Larney S; Santo T; Shanahan M; Memedovic S; Ali R; Farrell M
    Addiction; 2020 Jul; 115(7):1295-1305. PubMed ID: 31860767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
    Dunn KE; Tompkins DA; Bigelow GE; Strain EC
    JAMA Psychiatry; 2017 Sep; 74(9):885-893. PubMed ID: 28700791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine.
    Lim SCB; Schug S; Krishnarajah J
    Pain Med; 2019 Jan; 20(1):143-152. PubMed ID: 29309700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.